We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

In Risky Move, Alpharma Launches Generic Neurontin

Law360 (October 10, 2004, 12:00 AM EDT) -- In a risky move, Alpharma Inc. on Friday launched a generic version of Pfizer’s blockbuster epilepsy drug Neurontin without waiting for a court ruling on Pfizer's motion for a preliminary injunction....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.